Updated Jan. 11, 2024 12:47 pm ET Novartis has backed away from its pursuit of Cytokinetics,…
Tag: biotechnology services
GSK Buys Aiolos Bio for Up to $1.4 Bln
Updated Jan. 9, 2024 2:35 am ET GSK said it bought biopharmaceutical company Aiolos Bio for…
WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics
Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as pharmaceutical…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 Billion
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…
Merck to Buy Harpoon Therapeutics for $680 Million
Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680…
Ecstasy-for-Medicine Advocate Raises $100 Million
The Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, has raised…
How to Ride the Biotech Roller Coaster
With stocks starting to price in interest-rate cuts next year, the biotech sector has emerged as…
Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive
A federal appeals court said the U.S. government was right to challenge Illumina’s purchase of cancer-test…